Please login to the form below

Not currently logged in


This page shows the latest everolimus news and features for those working in and with pharma, biotech and healthcare.

BMS unveils long-term results for Opdivo in kidney cancer

BMS unveils long-term results for Opdivo in kidney cancer

alive at this time-point compared to 18% of those treated only with the standard chemotherapy drug everolimus.

Latest news

More from news
Approximately 8 fully matching, plus 64 partially matching documents found.

Latest from PMHub

  • Oncology drugs under AMNOG

    patients the comparator was a different targeted therapy, Afinitor (everolimus), rather than Nexavar - although for cytokine-pretreated patients the trial comparator could be used.The G-BA still exercises its right

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....